IRCT20160310026998N11已完成3 期
Effect of metformin in COVID-19 mortality rate and symptom improvement
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •All patients with Covid-19 symptoms in patients with the history of close contact with suspected people in the last 14 days
- •pulmonary involvement
- •normal or reduced cbc
- •reduced lymphocyte,
- •positive PCR
排除标准
- •patients with type I diabetes
- •Ketoacidosis
- •decompensated heart failure
- •severe kidney failure (GFR<30 ml/min)
- •metabolic acidosis
- •severe respiratory failure
- •immediate need for intubation
研究者
相似试验
已完成
3 期
Study of the metformin effect on the survival and recovery rate of patients with COVID-19corona virus.IRCT20160310026998N10Tabriz University of Medical Sciences200
尚未招募
不适用
Effect of Metformin Use on Mortality in Diabetic and Non Diabetic Patients With Sepsis and Septic Shock.Septic ShockNCT05572060Assiut University75
已完成
2 期
Investigating the effect of metformin on the activity of systemic lupus erythematosusIRCT20220817055730N1Ahvaz University of Medical Sciences64
招募中
2 期
The effect of Metformin on complication of strokesStroke.Stroke, not specified as haemorrhage or infarctionIRCT20160318027097N5Vice Chancellor for research of Ardebil University of Medical Sciences100
招募中
3 期
empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20220822055771N1Shahre-kord University of Medical Sciences50